SCHEMBL23578950

SCHEMBL23578950

CC(C)(C)OC(=O)N1CC(S(=O)(=O)CC2CNC2)C1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.47
▸ NAMPT P43490 1/20 0.40
▸ CHRNB2 P17787 2/20 0.36
▸ CHRNA4 P43681 2/20 0.36
▸ CHRNB4 P30926 1/20 0.36
▸ CHRNA3 P32297 1/20 0.36
▸ GPR119 Q8TDV5 4/20 0.36
▸ USP2 O75604 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ DDB1 Q16531 2/20 0.35
▸ CRBN Q96SW2 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21640381 0.81 NR1H2 (0.51) NR1H2NAMPTGPR119USP2SMN1; SMN2
SCHEMBL18505998 0.78 NR1H2 (0.53) NR1H2NAMPTCHRNB2CHRNA4CHRNB4
SCHEMBL30075813 0.77 LMNA (0.42) CHRNB2CHRNA4CHRNB4CHRNA3SMN1; SMN2
SCHEMBL23578989 0.77 CHRNB2 (0.33) CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL21098434 0.77 NR1H2 (0.48) NR1H2NAMPTGPR119USP2SMN1; SMN2
SCHEMBL16415001 0.77 NR1H2 (0.51) NR1H2NAMPTGPR119USP2SMN1; SMN2
SCHEMBL31609108 0.75 GPR119 (0.45) NR1H2GPR119USP2SMN1; SMN2KDM4E
SCHEMBL31609127 0.75 GPR119 (0.45) NR1H2GPR119USP2SMN1; SMN2KDM4E
Lithium Ion SCHEMBL21063447 0.74 NR1H2 (0.46) NR1H2NAMPTGPR119USP2SMN1; SMN2
SCHEMBL16497005 0.74 HPGD (0.48) NR1H2GPR119USP2SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115135642-B Inhibitors of EGFR mutant forms 缆图药品公司 2025-03-04 — — CN disclosed
EP-4081515-A1 INHIBITORS OF MUTANT FORMS OF EGFR Blueprint Medicines Corporation (US) 2022-11-02 — — EP disclosed
CN-115135642-A Inhibitors of mutant forms of EGFR 缆图药品公司 2022-09-30 — — CN disclosed
WO-2021133809-A1 INHIBITORS OF MUTANT FORMS OF EGFR BLUEPRINT MEDICINES CORPORATION (US) 2021-07-01 — — WO disclosed
Send feedback